 alpha wavelet power biomarker antidepressant treatment response bipolar depression mount evidence link property electroencephalograms eeg depressive patient outcome pharmacotherapy goal study develop eeg biomarker antidepressant treatment response would require single eeg measurement record rest -channel eeg inpatient suffer bipolar depression eye close eye open condition eeg measurement perform end short washout period follow previously unsuccessful pharmacotherapy calculate normalized wavelet power alpha rhythm use two referential montage average reference montage particular occipital oz channel wavelet power responder high nonresponders use novel classification algorithm able correctly predict outcome treatment sensitivity specificity propose biomarker require single eeg measurement consequently intrinsically different biomarkers exploit change prefrontal eeg induce pharmacotherapy give time